Genetic depletion of PRODH1 or pharmacological inhibition of PRODH1 using the reversible inhibitor L-tetrahydro-2-furoic acid (L-THFA) impair growth of breast cancer cells89 in vitro. Here, PRODH is linked to breast carcinoma.